Neogen (FRA:NG2) Retained Earnings : €520.1 Mil (As of Feb. 2024)

View and export this data going back to 1989. Start your Free Trial

What is Neogen Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Neogen's retained earnings for the quarter that ended in Feb. 2024 was €520.1 Mil.

Neogen's quarterly retained earnings increased from Aug. 2023 (€519.5 Mil) to Nov. 2023 (€520.3 Mil) but then declined from Nov. 2023 (€520.3 Mil) to Feb. 2024 (€520.1 Mil).

Neogen's annual retained earnings increased from May. 2021 (€444.1 Mil) to May. 2022 (€556.2 Mil) but then declined from May. 2022 (€556.2 Mil) to May. 2023 (€519.8 Mil).

Neogen Retained Earnings Historical Data

The historical data trend for Neogen's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neogen Retained Earnings Chart

Neogen Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Retained Earnings

Get a 7-Day Free Trial

374.81

438.99

444.09

556.16

519.84

Neogen Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Retained Earnings	Get a 7-Day Free Trial															522.54	519.84	519.52	520.27	520.08

Neogen Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Neogen (FRA:NG2) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Neogen (FRA:NG2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neogen Corp (FRA:NG2) » Definitions » Retained Earnings

Comparable Companies

GH SHC TWST NEO RDNT MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

NEOG:USA NG2:Germany

Address

620 Lesher Place, Lansing, MI, USA, 48912

Website

https://www.neogen.com

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.

Neogen (FRA:NG2) Headlines

No Headlines